Product Code: 978-1-68038-725-4
Paper Diagnostics Market Growth & Trends:
The global paper diagnostics market size is expected to reach USD 22.5 billion by 2030, registering a CAGR of 6.0% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing prevalence of diseases such as cancer, autoimmune diseases, and inflammatory diseases is one of the key factors expected to fuel the demand for novel and rapid diagnostics techniques, thereby driving the market during the forecast period. For instance, as per the American Cancer Society, in 2018, around 1.7 million new cancer cases are likely to be diagnosed and 609,640 individuals are poised to die due to cancer. The number of cancer cases is projected to rise by around 70.0% over the next two decades. This trend is anticipated to help the market gain momentum during the forecast period.
Rising R&D investments, technological advancements, and new product launches are the key growth strategies incorporated by companies to cater to rising needs. ARKRAY Inc.; Acon Laboratories, Inc.;Abbott; Bio-Rad Laboratories; Siemens healthcare; Abcam Plc; and Abingdon Health are some of the players focusing on new product development by rising R&D investments. For instance, in March 2017, ARKRAY Inc. launched saliva testing system, capable of measuring cariogenic bacteria, acidity & buffer capacity, occult blood, leukocyte & proteins, and ammonia from saliva. Moreover, in May 2017, ACON Laboratories, Inc. received U.S. FDA approval for its "Mission Urine Reagent Strips" for detection of Microalbumin and Creatinine.
Paper Diagnostics Market Report Highlights:
- Introduction of technologically advanced paper based diagnostic products, which offer sensitive and rapid results, is estimated to boost market growth over the forecast period
- Development of paper-based ELISA for detection of autoimmune antibodies in body fluid is expected to bolster the demand for technologically advanced & upgraded lateral flow assays over the forecast period
- The lateral flow assays segment held the largest revenue share in 2022, owing to wide application in disease diagnostics and associated advantages such as robust & rapid results, sensitivity, ease of use, and cost efficiency
- Paper based diagnostic devices are widely used as point-of-care diagnostics. Increasing inclination towards these devices can be attributed to advent of wax patterning technology, facilitating greater flexibility and adaptability
- In terms of application, the clinical diagnostics segment is likely to witness lucrative growth during the forecast period. Rising awareness regarding their benefits such as improved control and rapid results and growth prospects in area of nanomaterial & biomolecules are contributing to the growth of the segment
- North America led the overall market with a revenue share of 35.9% in 2022, owing to surging demand for self-testing devices coupled with well-established healthcare infrastructure
- Market leaders are involved in R&D activities to develop accurate, cost efficient, and sensitive paper based microfluidics. Focus on mergers and acquisitions, consistent system upgradation through R&D investments and fund raising are some of the key strategies adopted by players.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Kit Type
- 1.1.2. Device Type
- 1.1.3. Application
- 1.1.4. End-use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Kit type outlook
- 2.2.2. Device type outlook
- 2.2.3. Application outlook
- 2.2.4. End-use outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Paper Diagnostics Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Paper Diagnostics Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Paper Diagnostics Market: Kit Type Estimates & Trend Analysis
- 4.1. Paper Diagnostics Market: Key Takeaways
- 4.2. Paper Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Lateral Flow Assays
- 4.3.1. Lateral flow assays market estimates and forecasts, 2018 to 2030 (USD Billion)
- 4.4. Dipsticks
- 4.4.1. Dipsticks market estimates and forecasts, 2018 to 2030 (USD Billion)
- 4.5. Paper Based Microfluidics
- 4.5.1. Paper based microfluidics market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Paper Diagnostics Market: Device Type Estimates & Trend Analysis
- 5.1. Paper Diagnostics Market: Key Takeaways
- 5.2. Paper Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Diagnostic Devices
- 5.3.1. Diagnostics devices market estimates and forecasts, 2018 to 2030 (USD Billion)
- 5.4. Monitoring Devices
- 5.4.1. Monitoring devices market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Paper Diagnostics Market: Application Estimates & Trend Analysis
- 6.1. Paper Diagnostics Market: Key Takeaways
- 6.2. Paper Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Clinical Diagnostics
- 6.3.1. Clinical Diagnostics market estimates and forecasts, 2018 to 2030 (USD Billion)
- 6.3.2. Cancer
- 6.3.2.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Billion)
- 6.3.3. Infectious diseases
- 6.3.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
- 6.3.4. Liver disorders
- 6.3.4.1. Liver disorders market estimates and forecasts, 2018 to 2030 (USD Billion)
- 6.3.5. Other
- 6.3.5.1. Other market estimates and forecasts, 2018 to 2030 (USD Billion)
- 6.4. Food Quality Testing
- 6.4.1. Food quality testing market estimates and forecasts, 2018 to 2030 (USD Billion)
- 6.5. Environmental Monitoring
- 6.5.1. Environmental monitoring market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 7. Paper Diagnostics Market: End-use Estimates & Trend Analysis
- 7.1. Paper Diagnostics Market: Key Takeaways
- 7.2. Paper Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
- 7.3. Home Healthcare
- 7.3.1. Home Healthcare market estimates and forecasts, 2018 to 2030 (USD Billion)
- 7.4. Assisted Living Healthcare Facilities
- 7.4.1. Assisted Living Healthcare Facilities market estimates and forecasts, 2018 to 2030 (USD Billion)
- 7.5. Hospitals and Clinics
- 7.5.1. Hospitals and clinics market estimates and forecasts, 2018 to 2030 (USD Billion)
- 7.6. Others
- 7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 8. Paper Diagnostics Market: Regional Estimates & Trend Analysis
- 8.1. Regional Outlook
- 8.2. Paper Diagnostics Market by Region: Key Takeaways
- 8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.3.2. U.S.
- 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.3.3. Canada
- 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4. Europe
- 8.4.1. UK
- 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.2. Germany
- 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.3. France
- 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.4. Italy
- 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.5. Spain
- 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.6. Denmark
- 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.7. Sweden
- 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.4.8. Norway
- 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5. Asia Pacific
- 8.5.1. Japan
- 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.2. China
- 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.3. India
- 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.4. Australia
- 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.5. Thailand
- 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.5.6. South Korea
- 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.6. Latin America
- 8.6.1. Brazil
- 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.6.2. Mexico
- 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.6.3. Argentina
- 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.7. MEA
- 8.7.1. South Africa
- 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.7.2. Saudi Arabia
- 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.7.3. UAE
- 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
- 8.7.4. Kuwait
- 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Market Participant Categorization
- 9.2.1. Arkray, Inc.
- 9.2.1.1. Company overview
- 9.2.1.2. Financial performance
- 9.2.1.3. Product benchmarking
- 9.2.1.4. Strategic initiatives
- 9.2.2. Acon Laboratories, Inc.
- 9.2.2.1. Company overview
- 9.2.2.2. Financial performance
- 9.2.2.3. Product benchmarking
- 9.2.2.4. Strategic initiatives
- 9.2.3. Abbott (Alere Inc.)
- 9.2.3.1. Company overview
- 9.2.3.2. Financial performance
- 9.2.3.3. Product benchmarking
- 9.2.3.4. Strategic initiatives
- 9.2.4. Bio-Rad Laboratories, Inc.
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. Gvs S.P.A.
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. Siemens Healthcare Gmbh
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. Diagnostics For All, Inc.
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. Ffei Life Science (Biognostix)
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. Navigene
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. Micro Essential Laboratory Inc
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives
- 9.2.11. Kenosha Tapes
- 9.2.11.1. Company overview
- 9.2.11.2. Financial performance
- 9.2.11.3. Product benchmarking
- 9.2.11.4. Strategic initiatives